Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C83H109ClN14O20S4 |
| Molecular Weight | 1786.548 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 17 / 17 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CO[C@@H]1\C=C\C=C(C)\CC2=CC(N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(=O)CCSSC[C@H](NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](N)CC4=CC=CC=C4)C(=O)N[C@@H](CC5=CC=C(O)C=C5)C(=O)N[C@H](CC6=CNC7=C6C=CC=C7)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N3)C(N)=O)[C@]8(C)O[C@H]8[C@H](C)[C@@H]9C[C@@]1(O)NC(=O)O9)=C(Cl)C(OC)=C2
InChI
InChIKey=JVPMJFUBODFGNB-UFDFPQQFSA-N
InChI=1S/C83H109ClN14O20S4/c1-44-18-17-24-65(115-9)83(113)39-64(116-81(112)96-83)45(2)71-82(5,118-71)66(38-68(102)98(7)62-35-50(32-44)36-63(114-8)69(62)84)117-80(111)46(3)97(6)67(101)29-31-119-120-41-59(72(87)103)92-78(109)61-43-122-121-42-60(93-73(104)54(86)33-48-19-11-10-12-20-48)77(108)90-57(34-49-25-27-52(100)28-26-49)75(106)91-58(37-51-40-88-55-22-14-13-21-53(51)55)76(107)89-56(23-15-16-30-85)74(105)95-70(47(4)99)79(110)94-61/h10-14,17-22,24-28,35-36,40,45-47,54,56-61,64-66,70-71,88,99-100,113H,15-16,23,29-34,37-39,41-43,85-86H2,1-9H3,(H2,87,103)(H,89,107)(H,90,108)(H,91,106)(H,92,109)(H,93,104)(H,94,110)(H,95,105)(H,96,112)/b24-17+,44-18+/t45-,46+,47-,54-,56+,57+,58-,59+,60+,61+,64+,65-,66+,70+,71+,82+,83+/m1/s1
| Molecular Formula | C83H109ClN14O20S4 |
| Molecular Weight | 1786.548 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 17 / 17 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 17:01:30 GMT 2025
by
admin
on
Tue Apr 01 17:01:30 GMT 2025
|
| Record UNII |
L8993M383E
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
673318
Created by
admin on Tue Apr 01 17:01:30 GMT 2025 , Edited by admin on Tue Apr 01 17:01:30 GMT 2025
|
||
|
FDA ORPHAN DRUG |
630018
Created by
admin on Tue Apr 01 17:01:30 GMT 2025 , Edited by admin on Tue Apr 01 17:01:30 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1853254-97-3
Created by
admin on Tue Apr 01 17:01:30 GMT 2025 , Edited by admin on Tue Apr 01 17:01:30 GMT 2025
|
PRIMARY | |||
|
C131562
Created by
admin on Tue Apr 01 17:01:30 GMT 2025 , Edited by admin on Tue Apr 01 17:01:30 GMT 2025
|
PRIMARY | |||
|
300000032316
Created by
admin on Tue Apr 01 17:01:30 GMT 2025 , Edited by admin on Tue Apr 01 17:01:30 GMT 2025
|
PRIMARY | |||
|
118634103
Created by
admin on Tue Apr 01 17:01:30 GMT 2025 , Edited by admin on Tue Apr 01 17:01:30 GMT 2025
|
PRIMARY | |||
|
L8993M383E
Created by
admin on Tue Apr 01 17:01:30 GMT 2025 , Edited by admin on Tue Apr 01 17:01:30 GMT 2025
|
PRIMARY | |||
|
11298
Created by
admin on Tue Apr 01 17:01:30 GMT 2025 , Edited by admin on Tue Apr 01 17:01:30 GMT 2025
|
PRIMARY | INN |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TOXIN -> CONJUGATE | |||
|
|
TARGET -> INHIBITOR |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |